Skip to content

Nuvation Bio NUVB Enterprise value

Enterprise value at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$158.92B-2.6%
Pfizer logo
PfizerPFE
$222.4B+9.2%
Immunome logo
ImmunomeIMNM
$1.9B+470%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
$958.05M+65.4%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$2.62B+275%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$2.28B+84.0%

Other financials

Income statement

See full
Revenue$83.2M+2,599%
Gross profit$9.8M+1,340%
Operating income$3.9M+107%
Net income$5.4M+110%
EPS (diluted)$0.01+106%

Balance sheet

See full
Cash & equivalents$125.4M+161%
Total debt$57.2M+401%
Total equity$319.6M-23.8%
Total assets$610.2M+23.9%

Cash flow

See full
Operating cash flow$5.1M+112%
CapEx$48.0K-33.3%
Free cash flow$5.0M+112%

Valuation

See full
Market cap$2.1B+150%
P/S14.7×-62.0×

Profitability

See full
Gross margin54.3%+39.5pp
Operating margin-105%-52.0pp
Net margin-102.1%-50.6pp
FCF margin-93.5%-45.2pp

Returns & leverage

See full
Return on equity-39.5%-15.8pp
Debt / equity0.2×+0.2×
Current ratio7.4×-1.6×

Where this comes from

Calculated from Nuvation Bio’s reported figures.

The official record: Nuvation Bio’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvation Bio's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvation Bio's enterprise value?
Nuvation Bio (NUVB) reported enterprise value of $1.42B in Q1 2026.
How has Nuvation Bio's enterprise value changed year-over-year?
Nuvation Bio's enterprise value increased by 154.3% year-over-year, from $559.51M to $1.42B.
What is the long-term trend for Nuvation Bio's enterprise value?
Over 5 years (2020 to 2025), Nuvation Bio's enterprise value has grown at a 8.6% compound annual growth rate (CAGR), from $1.96B to $2.97B.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.